Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Fredun Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:539730 P/E (TTM) :27.2
ISIN Demat:INE194R01017 Div & Yield %:0.04 EPS (TTM) :61.21
Book Value (RS) :333.7139804 Market Cap (Rs Cr.):786.16 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Sep 2025)
Quarter Ended
(Sep 2024)
Quarter Ended
(% Var)
Sales 143.59 106.89 34.33
Other Income 0.00 0.00 0.00
PBIDT 22.34 13.95 60.14
Interest 7.73 5.31 45.57
PBDT 14.60 8.64 68.98
Depreciation 1.60 1.06 50.94
PBT 13.00 7.58 71.50
Tax 3.27 3.30 -0.91
Deferred Tax 0.00 0.00 0.00
PAT 9.73 4.27 127.87

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)